“The health status of women is linked to their fundamental freedoms and empowerment,” Susan Blumenthal, public health editor at the Huffington Post and former U.S. assistant surgeon general, and Jean Guo, a health policy intern at the Center for the Study of Presidency and Congress, write in the website’s “Healthy Living” blog in a post marking International Women’s Day, which was celebrated on Thursday. “With 3.4 billion women worldwide, women’s health is a global issue today. Yet, societal and environmental factors including poverty, discrimination, and violence are undermining the advancement of women’s health,” they write.
Odds Of Adult Mortality Lower In PEPFAR Focus Countries Compared With Non-Focus Countries, Study Shows
“In an attempt to assess the impact of U.S. international assistance for AIDS, researchers from Stanford University carried out a review of the relationship between U.S. support provided through the President’s Emergency Plan for AIDS Relief (PEPFAR) and adult mortality in PEPFAR focus countries in sub-Saharan Africa, and whether there were differences in outcome between these countries and other African countries which did not receive PEPFAR support,” NAM’s Aidsmap reports (Alcorn, 3/8). Presenting the results at the 19th Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle on Wednesday, Eran Bendavid said “[s]tatistical analysis found that adults living in focus countries between 2004 and 2008 had about a 20 percent lower odds of mortality compared to adults in non-focus countries,” the Center for Global Health Policy’s “Science Speaks” writes, adding, “Evidence for unintended health effects with respect to adult mortality is inconclusive, Bendavid said, but the likelihood of PEPFAR interventions eliciting unintended harms is low” (Mazzotta, 3/7).
“While PEPFAR and the Global Health Initiative (GHI) have dominated the global health community’s attention over the past few years, the President’s Malaria Initiative (PMI) has largely flown under the radar,” Rachel Silverman, a research assistant for Center for Global Development’s (CGD) global health team, and Victoria Fan, a research fellow at CGD, write in this post in the CGD’s “Rethinking U.S. Foreign Assistance Blog.” They add, “But just this month, the PMI released the results of an external evaluation which confirms what we’ve long suspected: PMI is doing a remarkably good job and generating ‘value for money’ in U.S. global health efforts” (3/7).
Nature examines how funding shortfalls are hampering global efforts to use drugs to curb the spread of HIV, writing, “[A]t this week’s annual Conference on RetroÂviruses and Opportunistic Infections in Seattle, Washington, there was growing concern that financial austerity in the United States and elsewhere is eating away at the funding needed for a worldwide prevention effort.” The journal cites proposed reductions “to direct international aid for HIV programs under the President’s Emergency Plan for AIDS Relief (PEPFAR)” in President Barack Obama’s FY 2013 budget request and an announcement by the Global Fund to Fight AIDS, Tuberculosis and Malaria last November that it had cancelled Round 11 grants “until 2014 because of tightening budgets in donor countries.”
“Nine global HIV/AIDS advocacy organizations sent a letter [.pdf] to President Obama Thursday asking him to rethink his fiscal year (FY) 2013 budget recommendation to slash $546 million in funding from the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) program,” the Center for Global Health Policy’s “Science Speaks” blog reports. The groups, which include AVAC: Global Advocacy for HIV Prevention, the HIV Medicine Association, and POZ Magazine, noted the request “recommended funding the Global Fund to Fight AIDS, Tuberculosis and Malaria at $1.65 billion — keeping the U.S. on track to reach its three-year commitment of $4 billion by 2013,” but in the letter stated, “[W]e must and we do strongly object to the apparent shoring up of the Global Fund budget request at the expense of the PEPFAR program. … These two programs are synergistic and often provide complementary services to the same communities,” the blog notes (Mazzotta, 3/2).
Will McKitterick, a research assistant with the Center for Global Development (CGD), in this “Rethinking U.S. Foreign Assistance” blog post summarizes Secretary of State Hillary Clinton’s “grueling marathon of Congressional committee hearings in defense of the FY2013 international affairs budget request.” The nine hours of hearings “ran the gamut of U.S. priorities in national security and foreign policy,” McKitterick writes, adding, “Congressional leaders seemed alarmed by reductions in global health spending and raised specific concerns over the administration’s ability to meet its commitments to its PEPFAR goal of placing six million people on life-sustaining treatment by 2013. Secretary Clinton assured the committees that cuts would be balanced by consolidating programs, finding efficiencies, improving partners’ capacity, and shifting more responsibilities to host countries” (3/2).
The Global Health Technologies Coalition (GHTC) — consisting of 40 global health research and advocacy organizations — on Tuesday held a congressional briefing to launch its third annual policy report, titled “Sustaining Progress: Creating U.S. policies to spur global health innovation,” GlobalPost’s “Global Pulse” blog reports (Donnelly, 2/28). The group is “warning deep cuts in the U.S. federal budget could reverse progress made on many diseases, including HIV/AIDS, tuberculosis and malaria,” VOA News writes (DeCapua, 2/28).
“Cash-strapped Swaziland is struggling to fund its HIV programs, and experts are warning of long-term damage to treatment and prevention schemes if steps are not taken to ring-fence funding and supplies,” the Mail & Guardian reports. About 200,000 people are living with HIV in Swaziland, nearly one quarter of the population, the newspaper notes, adding, “Until now the government has done well in terms of providing antiretroviral (ARV) treatment — achieving 78 percent coverage, just under the World Health Organization’s ‘universal coverage’ rate of 80 percent. But there are fears that uncertainty about funding streams and weak supply-chain management could result in a reversal of this progress.” The article discusses funding from the government, PEPFAR, and the Global Fund to Fight AIDS, Tuberculosis and Malaria; antiretroviral drug and testing supply problems; and the epidemic’s effect on children and life expectancy in the country (Redvers, 2/27).
KFF Webcast Assesses President Obama’s FY 2012 Budget Proposal, Potential Global Health Implications
The Kaiser Family Foundation held a live “In Focus” webcast on Tuesday “to assess President Obama’s fiscal year 2013 budget proposal and potential implications for global health,” the foundation writes on its website. The webcast features a panel of global health policy experts, moderated by Jen Kates, vice president and director of global health & HIV policy at the foundation, “who analyze the Administration’s proposal and how it compares to current funding levels, what may happen as the budget winds its way through Congress, and the implications for the future of U.S. global health programs,” according to the website, which provides links to the panelists’ biographies (.pdf), the foundation’s Budget Tracker and a fact sheet on U.S. funding for the Global Health Initiative, among other resources (2/22). A post in the Center for Global Health Policy’s “Science Speaks” blog provides quotes from panelists Beth Tritter, managing director of the Glover Park Group; Larry Nowels, a consultant with the U.S. Global Leadership Campaign and the ONE Campaign; and Ambassador Mark Dybul, co-director of the Global Health Law Program at Georgetown University Law Center’s O’Neill Institute for National and Global Health Law (Aziz, 2/21). The Medill School of Journalism’s “Medill on the Hill” also covered the discussion (Morello, 2/21).
In “the first in a series of conversations with officials at the Centers for Disease Control and Prevention (CDC) discussing the CDC’s role in global HIV and tuberculosis (TB) research and development,” the Center for Global Health Policy’s “Science Speaks” blog interviews Kayla Laserson, director of the Kenya Medical Research Institute (KEMRI)/CDC Field Research Station in Kisumu, Kenya. Laserson answers questions about her work with the CDC, the latest research projects underway at KEMRI/CDC, and progress in Kenya’s HIV response since she began working in Kisumu six years ago, among other topics (Mazzotta, 2/14).